CENTRO COMPRENSIVO DE CANCER — History
CCN 400135 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$20M
Latest Revenue (FY2022)
+38.3%
Revenue CAGR (3yr)
-100.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $11M | $17M | $20M | +18.0% | +38.3% |
| Operating Expenses | $31M | $37M | $47M | +27.6% | +23.0% |
| Operating Margin | -100.0% | -100.0% | -100.0% | +0.0% | +0.0% |
| Net Income | $-20M | $-20M | $-27M | -36.2% | +0.0% |
| Licensed Beds | 29 | 29 | 48 | +65.5% | +28.7% |
| Total Patient Days | 2,774 | 4,073 | 6,972 | +71.2% | +58.5% |
| Medicare Day % | 4% | 1% | 1% | -35.1% | -63.7% |
| Medicaid Day % | nan% | 48% | 39% | -18.8% | +nan% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +91.3% ($11M → $20M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+38.3%
This Hospital
+7.6%
State Avg
Latest Margin
-100.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $25M | -100.0% |
| FY2024 (proj) | $30M | -100.0% |
| FY2025 (proj) | $35M | -100.0% |